Acadia Pharmaceuticals (ACAD) Current Deferred Revenue (2010 - 2017)
Acadia Pharmaceuticals (ACAD) posted quarterly Current Deferred Revenue of $4.1 million for Q1 2017, up 56.28% quarter-over-quarter from $2.6 million in Q4 2016.
Acadia Pharmaceuticals (ACAD) Current Deferred Revenue (2010 - 2017) Analysis & Trends
Acadia Pharmaceuticals' Current Deferred Revenue history runs 7 years deep, the most recent figure standing at $4.1 million for Q1 2017.
- In Q1 2017, Current Deferred Revenue changed N/A year-over-year to $4.1 million; the TTM figure through Mar 2017 stood at $4.1 million (changed N/A YoY), while the FY2016 annual figure was $2.6 million, changed N/A from the prior year.
- Current Deferred Revenue for Q1 2017 stood at $4.1 million, up from $2.6 million in the prior quarter.
- The five-year high for Current Deferred Revenue was $4.1 million in Q1 2017, with the low at $15000.0 in Q3 2014.
- The 4-year median for Current Deferred Revenue is $111000.0 (2013), against an average of $876090.9.
- Peak annual rise in Current Deferred Revenue reached 69.92% in 2013, while the deepest fall reached 87.33% in 2013.
- Acadia Pharmaceuticals' Current Deferred Revenue stood at $55000.0 in 2013, then slumped by 72.73% to $15000.0 in 2014, then soared by 17526.67% to $2.6 million in 2016, then soared by 56.28% to $4.1 million in 2017.
- Business Quant data shows ACAD's Current Deferred Revenue at $4.1 million in Q1 2017, $2.6 million in Q4 2016, and $1.9 million in Q3 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Acadia Pharmaceuticals | 4.86 Bn | 3.90 Bn | 279.64 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2017 | 4.13 Mn |
| Dec 31, 2016 | 2.64 Mn |
| Sep 30, 2016 | 1.88 Mn |
| Jun 30, 2016 | 513,000.00 |
| Sep 30, 2014 | 15,000.00 |
| Jun 30, 2014 | 29,000.00 |
| Mar 31, 2014 | 42,000.00 |
| Dec 31, 2013 | 55,000.00 |
| Sep 30, 2013 | 80,000.00 |
| Jun 30, 2013 | 111,000.00 |
| Mar 31, 2013 | 140,000.00 |
| Dec 31, 2012 | 434,000.00 |
| Sep 30, 2012 | 266,000.00 |
| Jun 30, 2012 | 765,000.00 |
| Mar 31, 2012 | 683,000.00 |
| Dec 31, 2011 | 669,000.00 |
| Sep 30, 2011 | 708,000.00 |
| Jun 30, 2011 | 753,000.00 |
| Dec 31, 2010 | 690,000.00 |